Literature DB >> 12851769

[Overactive bladder--which diagnosis investigations are necessary before initiating primary treatment?].

B Schönberger1.   

Abstract

The symptom complex of frequency and urgency with or without urge incontinence is termed overactive bladder (OAB) according to the new definition by the International Continence Society. The background for this change in definition is the great economic and social importance of the disease, the rising costs in medicine, and the tendency to develop the simplest possible therapeutic strategies. Therapy consists of the administration of an anticholinergic/spasmolytic drug for at least 3 months. Although a great percentage of patients with OAB can be clinically identified, the required exclusion of "local pathologic and metabolic factors" calls for a minimal diagnostic program to come to fairly exact findings. This includes a detailed case history with standardized and evaluated questionnaires, a bladder diary, detailed clinical examination, urine analysis consisting of microscopic and microbiologic examination, uroflowmetry including measurement of residual urine, and examination of the kidneys and the upper urinary tract (determination of creatine and sonography). Minimally invasive tests to improve validity regarding obstruction and detrusor overactivity are being developed. These tests are intended to make an invasive pressure-flow study unnecessary. However, using the above-described minimal diagnostic program, one has to take into account that patients suffering from complaints without underlying idiopathic detrusor overactivity and with urgency/urge incontinence due to bladder outlet obstruction are referred for primary therapy with anticholinergic/antispastic drugs. In cases of neurologic signs, pathologic urinary findings, reduced urinary flow rate with residual urine, and problems of the upper urinary tract, further diagnostic studies are necessary. In any case, such patients need not undergo primary therapy on the basis of a clinical diagnosis. An ex iuvantibus therapy with anticholinergic drugs--even if limited to 3 months--is not acceptable if the diagnostic minimal program is not used.

Entities:  

Mesh:

Year:  2003        PMID: 12851769     DOI: 10.1007/s00120-003-0362-z

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  26 in total

1.  Overactive bladder: defining the disease.

Authors:  A J Wein
Journal:  Am J Manag Care       Date:  2000-07       Impact factor: 2.229

2.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

3.  Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies.

Authors:  Werner Schäfer; Paul Abrams; Limin Liao; Anders Mattiasson; Francesco Pesce; Anders Spangberg; Arthur M Sterling; Norman R Zinner; Philip van Kerrebroeck
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

4.  Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder.

Authors:  P Van Kerrebroeck; K Kreder; U Jonas; N Zinner; A Wein
Journal:  Urology       Date:  2001-03       Impact factor: 2.649

5.  Variability of 24-hour voiding diary variables among asymptomatic women.

Authors:  M P Fitzgerald; L Brubaker
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

6.  Development of a non-invasive strategy to classify bladder outlet obstruction in male patients with LUTS.

Authors:  J J M Pel; J L H R Bosch; J H M Blom; A A B Lycklama à Nijeholt; R van Mastrigt
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

7.  Data from frequency-volume charts versus filling cystometric estimated capacities and prevalence of instability in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Authors:  Ger E P M van Venrooij; Mardy D Eckhardt; Karel W H Gisolf; Tom A Boon
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

8.  Urinary incontinence symptom scores and urodynamic diagnoses.

Authors:  Mary P FitzGerald; Linda Brubaker
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

9.  A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence.

Authors:  H Madersbacher; M Halaska; R Voigt; S Alloussi; K Höfner
Journal:  BJU Int       Date:  1999-10       Impact factor: 5.588

10.  The relationship of detrusor instability and symptoms with objective parameters used for diagnosing bladder outlet obstruction: a prospective study.

Authors:  Bassem S Wadie; El-Husseiny E Ebrahim; Mohamed A Gomha
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

View more
  3 in total

Review 1.  [Dynamic bladder neck stenosis as a cause of psychogenic mictrition discomforts and mictrition disorders].

Authors:  E-A Günthert
Journal:  Urologe A       Date:  2004-05       Impact factor: 0.639

2.  [Neurogenic or idiopathic destrusor overactivity after failed antimuscarinic treatment : clinical value of external temporary electrostimulation].

Authors:  J Pannek; S Janek; J Noldus
Journal:  Urologe A       Date:  2010-04       Impact factor: 0.639

Review 3.  [Chronic pollakiuria: cystectomy or psychotherapy].

Authors:  A Kuffel; K P Kapitza; B Löwe; E Eichelberg; A Gumz
Journal:  Urologe A       Date:  2014-10       Impact factor: 0.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.